T1	Participants 108 145	patients with gastrointestinal cancer
T2	Participants 417 454	patients with gastrointestinal cancer
T3	Participants 747 817	512 patients with gastrointestinal cancer included in the TACTIC study
T4	Participants 827 1005	Some 89.2 per cent of patients had a primary tumour and 79.7 per cent underwent surgery with curative intent; 243 patients received perioperative RBC transfusion (median 3 units)
T5	Participants 1118 1126	LD group
T6	Participants 1152 1164	non-LD group
T7	Participants 1435 1471	patients with gastrointestinal cance
